Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 205

1.

[The Mayo Clinic Nicotine Dependence Center].

Hurt RD, Hays TJ, Croghan IT.

Cas Lek Cesk. 2017 Winter;156(1):17-18. Czech.

PMID:
28264576
2.

Response.

Hurt RD, Murphy JG, Dunn WF.

Chest. 2015 Jul;148(1):e30. doi: 10.1378/chest.15-0830. No abstract available.

PMID:
26149562
3.

Impact of a countywide smoke-free workplace law on emergency department visits for respiratory diseases: a retrospective cohort study.

Croghan IT, Ebbert JO, Hays JT, Schroeder DR, Chamberlain AM, Roger VL, Hurt RD.

BMC Pulm Med. 2015 Jan 22;15:6. doi: 10.1186/1471-2466-15-6.

5.

Combination varenicline and bupropion SR for tobacco-dependence treatment in cigarette smokers: a randomized trial.

Ebbert JO, Hatsukami DK, Croghan IT, Schroeder DR, Allen SS, Hays JT, Hurt RD.

JAMA. 2014 Jan 8;311(2):155-63. doi: 10.1001/jama.2013.283185.

6.

A randomized phase II clinical trial of high-dose nicotine patch therapy for smokeless tobacco users.

Ebbert JO, Croghan IT, Schroeder DR, Hurt RD.

Nicotine Tob Res. 2013 Dec;15(12):2037-44. doi: 10.1093/ntr/ntt097. Epub 2013 Jul 19.

7.

Smoking bans research--reply.

Hurt RD, Roger VL, Ebbert JO.

JAMA Intern Med. 2013 May 13;173(9):836-7. doi: 10.1001/jamainternmed.2013.928. No abstract available.

PMID:
23700023
8.

Myocardial infarction and sudden cardiac death in Olmsted County, Minnesota, before and after smoke-free workplace laws.

Hurt RD, Weston SA, Ebbert JO, McNallan SM, Croghan IT, Schroeder DR, Roger VL.

Arch Intern Med. 2012 Nov 26;172(21):1635-41.

9.

Tobacco dependence counseling in a randomized multisite clinical trial.

Croghan IT, Trautman JA, Winhusen T, Ebbert JO, Kropp FB, Schroeder DR, Hurt RD.

Contemp Clin Trials. 2012 Jul;33(4):576-82. doi: 10.1016/j.cct.2012.02.014. Epub 2012 Mar 3.

10.

Preventing lung cancer by treating tobacco dependence.

Hurt RD, Ebbert JO, Hays JT, McFadden DD.

Clin Chest Med. 2011 Dec;32(4):645-57. doi: 10.1016/j.ccm.2011.08.004. Review.

PMID:
22054877
11.

An exploration of site effects in a multisite trial of OROS-methylphenidate for smokers with attention deficit/hyperactivity disorder.

Covey LS, Hu MC, Green CA, Brigham G, Hurt RD, Adler L, Winhusen T.

Am J Drug Alcohol Abuse. 2011 Sep;37(5):392-9. doi: 10.3109/00952990.2011.596979.

12.

Roadmap to a tobacco epidemic: transnational tobacco companies invade Indonesia.

Hurt RD, Ebbert JO, Achadi A, Croghan IT.

Tob Control. 2012 May;21(3):306-12. doi: 10.1136/tc.2010.036814. Epub 2011 Aug 18.

13.

Zebrafish for the study of the biological effects of nicotine.

Klee EW, Ebbert JO, Schneider H, Hurt RD, Ekker SC.

Nicotine Tob Res. 2011 May;13(5):301-12. doi: 10.1093/ntr/ntr010. Epub 2011 Mar 8. Review.

14.

Residential treatment compared with outpatient treatment for tobacco use and dependence.

Hays JT, Croghan IT, Schroeder DR, Burke MV, Ebbert JO, McFadden DD, Hurt RD.

Mayo Clin Proc. 2011 Mar;86(3):203-9. doi: 10.4065/mcp.2010.0703. Epub 2011 Feb 9.

15.

Methylphenidate for treating tobacco dependence in non-attention deficit hyperactivity disorder smokers: a pilot randomized placebo-controlled trial.

Hurt RD, Ebbert JO, Croghan IT, Schroeder DR, Sood A, Hays JT.

J Negat Results Biomed. 2011 Jan 28;10:1. doi: 10.1186/1477-5751-10-1.

16.

Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States.

Croghan IT, Hurt RD, Ebbert JO, Croghan GA, Polk OD, Stella PJ, Novotny PJ, Sloan J, Loprinzi CL.

Z Gesundh Wiss. 2010 Feb;18(1):59-68. Epub 2009 Aug 11.

17.

Varenicline for smoking cessation: efficacy, safety, and treatment recommendations.

Ebbert JO, Wyatt KD, Hays JT, Klee EW, Hurt RD.

Patient Prefer Adherence. 2010 Oct 5;4:355-62.

18.

Varenicline for tobacco dependence treatment in recovering alcohol-dependent smokers: an open-label pilot study.

Hays JT, Croghan IT, Schroeder DR, Ebbert JO, Hurt RD.

J Subst Abuse Treat. 2011 Jan;40(1):102-7. doi: 10.1016/j.jsat.2010.08.009. Epub 2010 Oct 13.

PMID:
20947286
19.

Willingness of cancer patients to help family members to quit smoking.

Garces YI, Patten CA, Sinicrope PS, Decker PA, Offord KP, Brown PD, Clark MM, Rummans TA, Foote RL, Hurt RD.

Psychooncology. 2011 Jul;20(7):724-9. doi: 10.1002/pon.1768. Epub 2010 May 20.

PMID:
20878860
20.

Combination pharmacotherapy for stopping smoking: what advantages does it offer?

Ebbert JO, Hays JT, Hurt RD.

Drugs. 2010 Apr 16;70(6):643-50. doi: 10.2165/11536100-000000000-00000. Review.

Supplemental Content

Loading ...
Support Center